Mountain Crest Acquisition Corp. V (MCAG)
| Market Cap | 31.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -530.30K |
| Shares Out | 2.90M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 522 |
| Average Volume | 600 |
| Open | 11.00 |
| Previous Close | 11.00 |
| Day's Range | 11.00 - 11.00 |
| 52-Week Range | 10.71 - 11.49 |
| Beta | -0.01 |
| RSI | 2.18 |
| Earnings Date | Aug 15, 2025 |
About MCAG
Mountain Crest Acquisition Corp. V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. Mountain Crest Acquisition Corp. V is a subsidiary of Mountain Crest Global Holdings LLC. [Read more]
Financial Performance
Financial StatementsNews
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from the sta...
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed
NEW YORK, USA and SEOUL, Korea, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”), with ...
Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (NASDAQ: MCAG, the “Company”) today announced that it received an expected deficiency notification letter from the Listin...
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”) to t...
AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V
SINGAPORE and NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a clinical-stage biotechnology company, advancing a clinical stage pipeline designed to deploy multi-facete...